How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

• by Arthur Allen

• August 20, 2026

ACS report: Lung cancer deaths plunge as survival doubles

Lung cancer deaths fell by more than half among US males as smoking declined, earlier-stage diagnoses increased, and 5-year relative survival doubled.

• by Andrea Surnit

• September 28, 2026

• 6 min

Photodynamic therapy gains FDA approval for superficial BCC

Phase 3 trial data showed greater clinical and histological clearance than with placebo photodynamic therapy.

• by Kathryn Wighton

• September 15, 2026

• 2 min

B antigen transfusions may raise allergy risk

Patients with blood type O showed a stronger reaction signal in US regions with high alpha-gal syndrome prevalence.

• by Andrea Surnit

• August 27, 2026

• 4 min